Wilmington Savings Fund Society’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2K Buy
2,000
+200
+11% +$2.64K ﹤0.01% 997
2026
Q1
$24.8K Buy
1,800
+200
+13% +$3.01K ﹤0.01% 1020
2025
Q4
$28.8K Hold
1,600
﹤0.01% 994
2025
Q3
$29.6K Sell
1,600
-4,222
-73% -$66.3K ﹤0.01% 994
2025
Q2
$93.2K Buy
5,822
+784
+16% +$14K ﹤0.01% 1051
2025
Q1
$97.9K Sell
5,038
-2,262
-31% -$47.6K ﹤0.01% 1015
2024
Q4
$161K Hold
7,300
﹤0.01% 898
2024
Q3
$123K Buy
+7,300
New +$108K ﹤0.01% 965

Other funds holding CLBT

Wilmington Savings Fund Society's CLBT Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its Cellebrite (CLBT) stake by 11% in Q2 2026, buying an estimated $2.64K and bringing the position to 2,000 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Wilmington Savings Fund Society first reported a position in CLBT in Q3 2024 and has held it in 8 quarters since. The position peaked at $161K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Wilmington Savings Fund Society held 2,000 shares of Cellebrite worth $29.2K as of Q2 2026.
  • Wilmington Savings Fund Society bought 200 Cellebrite shares in Q2 2026, an estimated $2.64K.
  • Cellebrite made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #997 holding.
  • Wilmington Savings Fund Society first reported a position in Cellebrite in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's Cellebrite position peaked at $161K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.